Literature DB >> 2838960

Characterization of human papillomavirus type 6b DNA isolated from an invasive squamous carcinoma of the vulva.

M S Kasher1, A Roman.   

Abstract

Human papillomavirus type 6 (HPV 6) DNA was detected in an episomal form in DNA extracted from an invasive squamous carcinoma of the vulva. The viral DNA, designated HPV6-T70, was molecularly cloned. Restriction analysis of the HPV6-T70 genome revealed an insertion of approximately 35 bp in the 5' portion of the upstream regulatory region relative to the prototype HPV 6b genome, cloned from a benign genital wart (E.-M. de Villiers, L. Gissmann, and H. zur Hausen, 1981, J. Virol. 40, 932-935). However, sequence analysis of the upstream regulatory region identified several alterations in the purine-thymidine-rich region spanning nucleotides 7292-7400. One insertion of 24 bp at position 7323 represented an exact tandem duplication of nucleotides 7300-7323. A second insertion of 58 bp at position 7350 had 84% positional identity to immediately adjacent HPV 6 sequences (nucleotides 7303-7356) and was also similar to the 74-bp insertion found at position 7348 in HPV-6vc, cloned from an invasive verrucous carcinoma of the vulva (R. F. Rando, D. E. Groff, J. G. Chirikjian, and W. D. Lancaster, 1986, J. Virol. 57, 353-356). A deletion of 49 bp (nucleotides 7351-7399) immediately followed the 58-bp insertion. The cloned HPV6-T70 DNA induced the morphological transformation of NIH 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838960     DOI: 10.1016/0042-6822(88)90676-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.

Authors:  B Rapp; A Pawellek; F Kraetzer; M Schaefer; C May; K Purdie; K Grassmann; T Iftner
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

2.  Characterization of human papillomavirus type 57b: transforming activity and comparative sequence analysis as probes for biological determinants associated with high-risk oncogenic viruses.

Authors:  J M Trujillo; T C Wu; P Mounts
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  Human papillomavirus type 18 and intraepithelial lesions of the cervix.

Authors:  C M McLachlin; J E Tate; J C Zitz; E E Sheets; C P Crum
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

4.  Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms.

Authors:  D Smotkin; H Prokoph; F O Wettstein
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

Review 5.  Human papillomaviruses: are we ready to type?

Authors:  A Roman; K H Fife
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

6.  The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties.

Authors:  J R Gage; C Meyers; F O Wettstein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Human papillomavirus type 6b DNA required for initiation but not maintenance of transformation of C127 mouse cells.

Authors:  D Morgan; G Pecoraro; I Rosenberg; V Defendi
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential.

Authors:  M S Barbosa; W C Vass; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  PCR analysis of the upstream regulatory region of human papillomavirus genomes in cervical intraepithelial neoplasia and cervical carcinoma.

Authors:  Y K Donaldson; M J Arends; E Duvall; C C Bird
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

10.  Analysis of human papillomavirus types in exophytic condylomata acuminata by hybrid capture and Southern blot techniques.

Authors:  D R Brown; J T Bryan; H Cramer; K H Fife
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.